821
Views
5
CrossRef citations to date
0
Altmetric
Articles

Polyarginine and PEG-AEYLR comodified nanostructured lipid carrier: 10mol% uncleavable PEG-AEYLR showed no shielding effect to polyarginine in vitro while maintaining good tumor targeting in vivo

, , , , , & show all
Pages 284-292 | Received 04 Jan 2017, Accepted 13 Mar 2017, Published online: 30 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jianwen Zhou, Mingshuang Sun, Shanshan Jin, Li Fan, Wenquan Zhu, Xiaoyu Sui, Lixin Cao, Chunrong Yang & Cuiyan Han. (2019) Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Drug Delivery 26:1, pages 281-289.
Read now
Maryam Ghasemi, Effat Alizadeh, Khatereh Saei Arezoumand, Behzad Fallahi Motlagh & Nosratollah Zarghami. (2018) Ciliary neurotrophic factor (CNTF) delivery to retina: an overview of current research advancements. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 1694-1707.
Read now

Articles from other publishers (3)

Elahe Majidnia, Mehdi Ahmadian, Hossein Salehi & Noushin Amirpour. (2022) Development of an electrospun poly(ε-caprolactone)/collagen-based human amniotic membrane powder scaffold for culturing retinal pigment epithelial cells. Scientific Reports 12:1.
Crossref
Bavani Subramaniam, Norhafiza M. Arshad, Sharan Malagobadan, Misni Misran, Shaik Nyamathulla, Kein Seong Mun & Noor Hasima Nagoor. (2021) Development and Evaluation of 1′-Acetoxychavicol Acetate (ACA)-Loaded Nanostructured Lipid Carriers for Prostate Cancer Therapy. Pharmaceutics 13:4, pages 439.
Crossref
Bavani Subramaniam, Zahid H. Siddik & Noor Hasima Nagoor. (2020) Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. Journal of Nanoparticle Research 22:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.